Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines that unlock high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead candidate, FOG-001, is the first direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in colorectal cancer, desmoid tumors, and a range of other Wnt/β-catenin-driven tumors. Parabilis is also advancing investigational degraders of ERG and ARON for the treatment of prostate cancer, as well as other preclinical programs. What’s the opportunity? The Senior Director, Medical Writing will join the growing Clinical Operations organization and serve as the strategic and operational leader for all medical writing activities across clinical development programs. This role will own the authorship, quality, and delivery of critical clinical and regulatory documentation and will ensure that Parabilis’ scientific and clinical narratives are communicated with clarity, accuracy, and regulatory excellence. This is a high-impact position that will partner cross-functionally with Clinical Development, Regulatory Affairs, Program Management, Biometrics, Nonclinical, and CMC teams. The Senior Director will shape documentation strategy for a rapidly advancing first-in-class therapeutic modality and will directly influence clinical execution, regulatory interactions, and the company’s ability to translate groundbreaking science to patient benefit.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree